Socioeconomic Status Drives Racial Disparities in HPV‐negative Head and Neck Cancer Outcomes

Male Squamous Cell Carcinoma of Head and Neck Health Status Disparities Middle Aged White People 3. Good health Black or African American Survival Rate 03 medical and health sciences Logistic Models 0302 clinical medicine Social Class Head and Neck Neoplasms North Carolina Humans Female Aged Neoplasm Staging Proportional Hazards Models Retrospective Studies
DOI: 10.1002/lary.29252 Publication Date: 2020-11-10T22:36:27Z
ABSTRACT
Objectives/HypothesisTo determine drivers of the racial disparity in stage at diagnosis and overall survival (OS) between black and white patients with HPV‐negative head and neck squamous cell carcinoma (HNSCC).Study DesignRetrospective cohort study.MethodsData were examined from of a population‐based HNSCC study in North Carolina. Multivariable logistic regression and Cox proportional hazards models were used to assess racial disparities in stage at diagnosis and OS with sequential adjustment sets.ResultsA total of 340 black patients and 864 white patients diagnosed with HPV‐negative HNSCC were included. In the unadjusted model, black patients had increased odds of advanced T stage at diagnosis (OR 2.0; 95% CI [1.5–2.5]) and worse OS (HR 1.3, 95% CI 1.1–1.6) compared to white patients. After adjusting for age, sex, tumor site, tobacco use, and alcohol use, the racial disparity persisted for advanced T‐stage at diagnosis (OR 1.7; 95% CI [1.3–2.3]) and showed a non‐significant trend for worse OS (HR 1.1, 95% CI 0.9–1.3). After adding SES to the adjustment set, the association between race and stage at diagnosis was lost (OR: 1.0; 95% CI [0.8–1.5]). Further, black patients had slightly favorable OS compared to white patients (HR 0.8, 95% CI [0.6–1.0]; P = .024).ConclusionsSES has an important contribution to the racial disparity in stage at diagnosis and OS for HPV‐negative HNSCC. Low SES can serve as a target for interventions aimed at mitigating the racial disparities in head and neck cancer.Level of Evidence4 Laryngoscope, 131:1301–1309, 2021
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (48)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....